Excessive Underarm Sweating: Why It Happens and How It Is Treated

What Causes Excessive Underarm Sweating?

Excessive sweating has two fundamentally different origins, and telling them apart shapes every treatment decision.

Primary focal hyperhidrosis is the most common cause of heavy, isolated underarm sweating in otherwise healthy people 1Ref 1Walling HW (2011).Clinical differentiation of primary from secondary hyperhidrosis.Primary hyperhidrosis is the most common cause of isolated bilateral focal sweating; distinguished from secondary by bilateral symmetry, no nocturnal sweating, onset before age 25, and functional impairment. In this condition, the nerve signals to the eccrine sweat glands are chronically overactive — not because of heat or exertion, but as a baseline state. It typically begins in childhood or adolescence, affects both underarms equally, stops completely during sleep, and often runs in families. No underlying disease is causing it.

Clinical criteria that suggest primary hyperhidrosis include: focal visible sweating lasting at least six months; bilateral and symmetric distribution; at least one episode per week; onset before age 25; positive family history; and functional impairment in daily life 2Ref 2Walling HW (2011).Clinical differentiation of primary from secondary hyperhidrosis.Diagnostic criteria for primary hyperhidrosis including bilateral symmetric focal sweating, absence during sleep, onset at or before age 25, family history, at least weekly episodes; secondary hyperhidrosis features later onset, asymmetry, nocturnal pattern.

Secondary hyperhidrosis is sweating caused by something else — thyroid overactivity, poorly controlled diabetes, certain medications (including some antidepressants, opioids, and blood pressure drugs), menopause, infection, or, rarely, a tumor affecting nerve pathways 2Ref 2Walling HW (2011).Clinical differentiation of primary from secondary hyperhidrosis.Diagnostic criteria for primary hyperhidrosis including bilateral symmetric focal sweating, absence during sleep, onset at or before age 25, family history, at least weekly episodes; secondary hyperhidrosis features later onset, asymmetry, nocturnal pattern. Secondary causes are more likely when sweating is generalized, occurs at night, is new in adulthood, or comes with other symptoms. A clinician's job is to distinguish which type is present before recommending treatment.

How Common Is Hyperhidrosis, and Who Gets It?

Hyperhidrosis is more prevalent than many people realize. A nationally representative U.S. survey estimated that about 4.8% of the population — roughly 15 million people — have the condition 3Ref 3Doolittle J, Walker P, Mills T, Thurston J (2016).Hyperhidrosis: an update on prevalence and severity in the United States.Hyperhidrosis affects approximately 4.8% of the U.S. population (roughly 15 million people); highest prevalence in those under 30; similar prevalence across sexes. Despite this, only about half of people with hyperhidrosis discuss it with a clinician, and around 60% do not recognize it as a medical condition 4Ref 4Parashar K, Adlam T, Potts G (2023).The Impact of Hyperhidrosis on Quality of Life: A Review of the Literature.Up to 48% of patients report poor or very poor quality of life; only 51% discuss the condition with a clinician; about 60% do not recognize it as a medical condition; stress-sweat cycle reinforces anxiety and social impairment.

Primary hyperhidrosis has the highest prevalence in people under 30 and is reported roughly equally in men and women 3Ref 3Doolittle J, Walker P, Mills T, Thurston J (2016).Hyperhidrosis: an update on prevalence and severity in the United States.Hyperhidrosis affects approximately 4.8% of the U.S. population (roughly 15 million people); highest prevalence in those under 30; similar prevalence across sexes. A family history substantially raises the likelihood, which points to a heritable component in the overactive nerve signaling.

What Is the Treatment Ladder for Axillary Hyperhidrosis?

Treatments are matched to severity and stepped up if earlier options are insufficient.

Prescription-strength aluminum chloride antiperspirant is almost always the first step. Applied at night to completely dry skin, it temporarily blocks sweat ducts. This is meaningfully different from over-the-counter antiperspirants and represents the standard starting point in guidelines.

Iontophoresis passes a low-level electrical current through water-soaked skin, temporarily reducing sweat gland output. It is highly effective for palms and soles and is also used for underarms, but requires regular maintenance sessions.

Botulinum toxin (Botox) injections into the underarm temporarily block the nerve signals that trigger the sweat glands. A 2025 meta-analysis of 12 randomized controlled trials involving 904 participants found that botulinum toxin type A produced substantially greater sweat reduction than placebo by gravimetric measurement, with a safety profile comparable to placebo 5Ref 5Sun J, Gao L, et al. (2025).Efficacy and Safety of Botulinum Toxin Type A in Primary Axillary Hyperhidrosis: A Meta-analysis and Systematic Review.Meta-analysis of 12 RCTs (904 participants): botulinum toxin type A produced substantially greater sweat reduction than placebo by gravimetric measurement; safety profile comparable to placebo; effects last approximately 6 months. Effects typically last around six months and the treatment is repeatable. Botox for hyperhidrosis is covered by some insurance plans when conservative treatments have been tried first — your clinician can document medical necessity.

Topical anticholinergic medications offer a newer option. Topical glycopyrronium bromide 1% cream is FDA-approved for primary axillary hyperhidrosis; a phase IIIa randomized controlled trial found it produced significantly greater sweat reduction than placebo (57% vs 34% achieving at least 50% reduction), with most side effects mild and no treatment discontinuations required 6Ref 6Abels C, Soeberdt M, Kilic A, Reich H, Knie U, Jourdan C, Schramm K, Heimstaedt-Muskett S, Masur C, Szeimies R-M (2021).A glycopyrronium bromide 1% cream for topical treatment of primary axillary hyperhidrosis: efficacy and safety results from a phase IIIa randomized controlled trial.Phase IIIa RCT: topical glycopyrronium bromide 1% achieved at least 50% sweat reduction in 57% of participants vs 34% placebo; quality-of-life response 60% vs 26%; side effects mostly mild, no treatment discontinuations. Oral anticholinergics (such as oxybutynin) are also used — a 2023 meta-analysis of six RCTs found oxybutynin significantly superior to placebo on clinical severity scores, though CNS side effects including dizziness and drowsiness occurred more frequently with oral dosing 7Ref 7El-Samahy M, Mouffokes A, Badawy MM, Amro S, Fayad T, Abdelwahab OA (2023).Safety and efficacy of oxybutynin in patients with hyperhidrosis: systematic review and meta-analysis of randomized controlled trials.Meta-analysis of 6 RCTs (293 patients): oxybutynin significantly superior to placebo on HDSS (RR 1.68, p=0.002); CNS adverse effects significantly more frequent with oxybutynin including dizziness and drowsiness.

Microwave thermolysis (miraDry) uses controlled microwave energy to permanently reduce sweat glands in the underarm. A clinical evaluation found that 90% of patients achieved meaningful reductions in sweating at 12-month follow-up, with durable results 8Ref 8Hong HC, Lupin M, O'Shaughnessy KF (2012).Clinical evaluation of a microwave device for treating axillary hyperhidrosis.Clinical evaluation: 90.3% of participants achieved severity scores of 1-2 at 12 months; 90.3% experienced at least 50% reduction in sweat production; durable results with one to three sessions; temporary local side effects resolved completely. This is a longer-lasting but more costly option, typically out-of-pocket.

Surgery (endoscopic thoracic sympathectomy) cuts the nerve supply to the sweat glands and is reserved for severe cases that have not responded to other treatments. It carries a meaningful risk of compensatory sweating elsewhere on the body and is not a first-line option.

How Does Hyperhidrosis Affect Daily Life?

The quality-of-life burden of hyperhidrosis is substantial and often underestimated. A 2023 review of the literature found that up to 48% of people with hyperhidrosis report poor or very poor quality of life, with emotional consequences including embarrassment, shame, and anxiety 4Ref 4Parashar K, Adlam T, Potts G (2023).The Impact of Hyperhidrosis on Quality of Life: A Review of the Literature.Up to 48% of patients report poor or very poor quality of life; only 51% discuss the condition with a clinician; about 60% do not recognize it as a medical condition; stress-sweat cycle reinforces anxiety and social impairment. The condition creates a reinforcing cycle: stress triggers sweating, and visible sweating in social situations amplifies stress.

When discussing this condition with a clinician, describing its impact on work, social life, and clothing choices matters — that impact informs treatment decisions. You do not need to describe it as trivial or manageable if it is not.

What Will a Clinician Evaluate?

A primary care physician or dermatologist can evaluate, confirm the diagnosis, and start first-line treatment. The workup focuses on distinguishing primary from secondary hyperhidrosis 2Ref 2Walling HW (2011).Clinical differentiation of primary from secondary hyperhidrosis.Diagnostic criteria for primary hyperhidrosis including bilateral symmetric focal sweating, absence during sleep, onset at or before age 25, family history, at least weekly episodes; secondary hyperhidrosis features later onset, asymmetry, nocturnal pattern.

A clinician is likely to ask: Where does the sweating occur — underarms only, or other areas as well? Is it the same on both sides? Does it happen at rest and in cool temperatures, or mainly with exertion or heat? Does it stop during sleep? How long has this been happening, and has it changed? Is there a family history? Have you started any new medications?

Depending on the answers, a clinician may check thyroid function (TSH and T4) to rule out hyperthyroidism, fasting glucose or HbA1c if diabetes is a consideration, or — in the office — a starch-iodine (Minor's) test to map which areas are sweating most heavily and guide Botox injection placement.

A dermatologist can offer the full treatment range including injections and referral for microwave thermolysis. You do not need to manage this condition without support — hyperhidrosis is recognized, measurable, and broadly treatable.